**Author details**

Taruneet Kaur, Rajeev Kapila and Suman Kapila\* Animal Biochemistry Department, ICAR-National Dairy Research Institute, Karnal, India

\*Address all correspondence to: skapila69@gmail.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**223**

*MicroRNAs as Next Generation Therapeutics in Osteoporosis*

[10] Obernosterer G, Leuschner PJ, Alenius M, Martinez J. Post-

transcriptional regulation of microRNA expression. RNA. 2006;**12**(7):1161-1167

[11] Huntzinger E, Izaurralde E. Gene silencing by microRNAs: Contributions of translational repression and mRNA decay. Nature Reviews. Genetics.

[12] Lian JB, Stein GS, Van Wijnen AJ, Stein JL, Hassan MQ, Gaur T, et al. MicroRNA control of bone formation and homeostasis. Nature Reviews. Endocrinology. 2012;**8**(4):212

[13] Sun M, Zhou X, Chen L, Huang S, Leung V, Wu N, et al. The regulatory roles of microRNAs in bone remodeling

and perspectives as biomarkers in osteoporosis. BioMed Research International. 2016;**2016**:1652417

[14] Ell B, Kang Y. MicroRNAs as

[15] Ge DW, Wang WW, Chen HT, Yang L, Cao XJ. Functions of microRNAs in osteoporosis. European Review for Medical and Pharmacological Sciences.

[16] Dong J, Cui X, Jiang Z, Sun J. MicroRNA-23a modulates tumor necrosis factor-alpha-induced osteoblasts apoptosis by directly targeting fas. Journal of Cellular Biochemistry. 2013;**114**(12):2738-2745

[17] Su N, Yang J, Xie Y, Du X, Chen H, Zhou H, et al. Bone function, dysfunction and its role in diseases including critical illness. International Journal of Biological

[18] Guntur A, Rosen C. Bone as an endocrine organ. Endocrine Practice.

2017;**21**(21):4784-4789

Sciences. 2019;**15**(4):776

2012;**18**(5):758-762

regulators of bone homeostasis and bone metastasis. BoneKEy Reports. 2014;**3**:549

2011;**12**(2):99

*DOI: http://dx.doi.org/10.5772/intechopen.91223*

[1] Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simões MJ, Cerri PS. Biology of bone tissue: Structure, function, and factors that influence bone cells. BioMed Research International. 2015;**2015**:1-17

[2] Hayrapetyan A, Jansen JA, van den Beucken JJ. Signaling pathways involved in osteogenesis and their application for bone regenerative medicine. Tissue Engineering Part B: Reviews.

[3] Sözen T, Özışık L, Başaran NÇ. An overview and management of osteoporosis. European Journal of Rheumatology. 2017;**4**(1):46

[4] Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. Journal of Bone and Mineral Research. 1994;**9**(8):1137-1141

[5] Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International.

2006;**17**(12):1726-1733

[6] Rosen CJ. Postmenopausal

osteoporosis. The New England Journal of Medicine. 2005;**353**(6):595-603

[7] Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, et al. Osteoporosis in the European Union: Medical management, epidemiology and economic burden. Archives of Osteoporosis. 2013;**8**(1-2):136

[8] Malhotra N, Mithal A. Osteoporosis in Indians. The Indian Journal of Medical Research. 2008;**127**(3):263-268

[9] Sharma D, Rao S. Osteoporosis epidemiology review and panacea osteoporosis evaluation study. Journal of the Indian Medical Association. 2000;**98**(10):655, 658-655, 659

**References**

2014;**21**(1):75-87

*MicroRNAs as Next Generation Therapeutics in Osteoporosis DOI: http://dx.doi.org/10.5772/intechopen.91223*
